Manufacturing Metrics Sample Clauses

Manufacturing Metrics. TSMC agrees to provide pertinent manufacturing metrics to Company, including but not limit to data such as regarding Company Process Yield, Cycle Time and Company Process development. It is Company’s desire to receive raw data for these metrics such that the data could be calculated using Company standard formulas, and to be able to access this data from the Foundry in real time, using the most effective method. Foundry agrees to set up communication system in this section at the shortest time possible.
AutoNDA by SimpleDocs
Manufacturing Metrics. To ensure quality and customer service, Manufacturer will establish and use a standard set of manufacturing metrics (“Manufacturing Metrics”) through which Manufacturer will ____________________ [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. attempt continually to improve yields and delivery accuracy and to reduce costs and defect rates. The Manufacturing Metrics shall be made immediately available upon request, and to include, at a minimum, information concerning: (a) Product inventory (finished goods, work-in-progress and raw materials); (b) yield (at various production points) and improvement plans for yield; (c) delivery accuracy; (d) returns (number of units, repair time); (e) fault statistics (most frequent defects found, faulty parts, cause and corrective action); (f) failure rates (assembly, first pass test, final test, final inspection, labeling, packaging, shipping and improvement plans for each of the foregoing). On a regular basis (but [ * ]), Manufacturer will: (a) provide BUYER with copies of the Manufacturing Metrics; and (b) engage in status reviews concerning the Manufacturing Metrics.
Manufacturing Metrics. SMIC agrees to provide customary manufacturing metrics to Spansion, including but not limited to data such as process Yield, cycle time, tool downtime, Scrap and rework. It is Spansion’s desire to receive raw data for these metrics such that the data could be calculated using Spansion standard formulas, and to be able to access this data from SMIC in real time, using the most effective method.
Manufacturing Metrics. TSMC agrees to provide reasonable customary manufacturing metrics to IDT including data applicable to Wafers as mutually agreed. In addition, TSMC agrees to provide reasonable raw data for these metrics such that the data could be calculated using IDT’s standard formulae, and to enable IDT to access this data from TSMC in real time.
Manufacturing Metrics. AMPTECH agrees to provide pertinent manufacturing metrics to WJ, including but not limited to, data regarding process yield, cycle time and Process development.
Manufacturing Metrics. GCS agrees to provide pertinent manufacturing metrics to WJ, including but not limit to data regarding process yield, cycle time and Process development. WJ shall upon request receive in a timely manner raw data for these metrics such that the data could be calculated using WJ standard formulas as listed in the Specifications.
Manufacturing Metrics. Manufacturer shall establish and use a standard set of manufacturing metrics (“Metrics”) through which Manufacturer will accurately discover data to guide continuous improvement in [****] . At a minimum, Metrics shall be collected on a weekly basis concerning: (a) [****] (defined as the sum of [****] ); (b) [****] (at [****] ); (c) [****] ; (d) [****] ( [****] ); (e) [****] ( [****] ); (f) [****] ( [****] ) along with written improvement plan(s) for any step indicating an out-of-control or degrading condition.
AutoNDA by SimpleDocs

Related to Manufacturing Metrics

  • Product Specifications The Company agrees that all Products sold to Xxxx hereunder shall conform to the respective specifications set forth on Schedule A or to such other specifications as are from time to time agreed upon by the Parties.

  • Manufacturing License Subject to the terms of this Agreement, including without limitation Section 2.2, Theravance grants to GSK an exclusive license under the Theravance Patents and Theravance Know-How to make and have made API Compound or formulated Alliance Product in the Territory.

  • API If the Software offers integration capabilities via an API, your use of the API may be subject to additional costs or Sage specific policies and terms and conditions (which shall prevail in relation to your use of the API). You may not access or use the API in any way that could cause damage to us or the Software, or in contravention of any applicable laws. We reserve the right in our sole discretion, to: (i) update any API from time to time; (ii) place limitations around your use of any API; and (iii) deny you access to any API in the event of misuse by you or to otherwise protect our legitimate interests.

  • Manufacturing Services Jabil will manufacture the Product in accordance with the Specifications and any applicable Build Schedules. Jabil will reply to each proposed Build Schedule that is submitted in accordance with the terms of this Agreement by notifying Company of its acceptance or rejection within three (3) business days of receipt of any proposed Build Schedule. In the event of Jabil’s rejection of a proposed Build Schedule, Jabil’s notice of rejection will specify the basis for such rejection. When requested by Company, and subject to appropriate fee and cost adjustments, Jabil will provide Additional Services for existing or future Product manufactured by Jabil. Company shall be solely responsible for the sufficiency and adequacy of the Specifications [***].

  • Manufacturing and Marketing Rights The Company has not granted rights to manufacture, produce, assemble, license, market, or sell its products to any other person and is not bound by any agreement that affects the Company's exclusive right to develop, manufacture, assemble, distribute, market, or sell its products.

  • Product Quality 4.1 The following provisions shall apply to Product after Production:

  • Manufacturing (a) The Supplier shall without limitation be responsible, at no additional cost to the Purchaser, for: sourcing and procuring all raw materials for the Products; obtaining all necessary approvals, permits and licenses for the manufacturing of the Products; providing sufficient qualified staff and workers to perform the obligations under this Purchase Agreement; implementing and maintaining effective inventory and production control procedures with respect to the Products; and handling other matters as reasonably requested by the Purchaser from time to time.

  • Manufacturing Rights Manufacturing Rights will be governed by Attachment 6.

  • Joint Manufacturing Committee In accordance with Section 2.5(c)(iv), the Parties shall promptly establish and convene a joint Manufacturing Committee (the “JMC”) for the overall coordination and oversight of the Manufacturing of clinical and commercial supplies of the Product under this Agreement as provided in the Manufacturing Plan (including the Manufacture of API, Drug Product and Finished Product). The JMC shall consist of representatives of each Party, and shall operate by procedures, as set forth in Section 2.5. The role of the JMC shall be:

  • Manufacturing Costs Patheon shall be allowed to adjust the Fees: (i) for costs associated with the conversion of Granulations and Components into Drug Product (the “Conversion Costs”) in respect of the Drug Product based on the most recently available final Producers’ Price Index for Pharmaceutical Product as published by the U.S. Bureau of Labor Statistics or any governmental successor thereto (“PPI”) using the procedure set forth in Section 4.3 and (ii) for Component Costs to pass on the actual amount of any increase or decrease in such costs without xxxx-up. For each Contract Year in which Patheon is entitled to adjust the Fees Patheon shall provide Client with written notice of any change in the Fees within 30 days of receipt by Patheon of the Annual Forecast. The Parties agree that the Fees shall not be adjusted more than once per Contract Year, however this limitation shall not include price adjustments under section 4.3 or 4.4. In addition, notwithstanding anything herein to the contrary, Manufacturing Fees associated with Conversion Costs shall not be increased by greater than [***]% per annum in any Contract Year during the Term. There shall be no similar limitation in terms of increases in Component Costs which shall be passed on to Client in an amount equal to the actual increase paid by Patheon without markup.

Time is Money Join Law Insider Premium to draft better contracts faster.